ClinicalTrials.gg

Program

emugrobart

Also written as “RO7204239” and “GYM329”.

Its studies are mostly in Muscular Atrophy, Spinal · Muscular Dystrophy, Facioscapulohumeral · Diabetes Mellitus, Type 2 · Obesity, led by Hoffmann-La Roche.

Furthest: phase 3, since Nov 1, 20215 company-led studies, 2 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Hoffmann-La Roche52 open or runningphase 3since Nov 1, 2021Dec 24, 2020none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 24, 2020First study: phase 1 study in Healthy VolunteersFirst studyNCT04708847 · 30 enrolled · Netherlands
  2. Nov 1, 2021Phase 3 study in Muscular Atrophy, SpinalNCT05115110 · 97 enrolled · United States, Australia, Belgium and more
  3. Sep 16, 2022Phase 2 study in Muscular Dystrophy, FacioscapulohumeralNCT05548556 · 51 enrolled · United States, Denmark, Italy and more
  4. May 2, 2025Phase 2 study in ObesityNCT06965413 · 285 enrolled · United States, Poland, Spain and more
  5. Aug 15, 2025Phase 1 study in Diabetes Mellitus, Type 2NCT07137585 · 30 enrolled · Germany

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07137585Diabetes Mellitus, Type 2 · Germany1Active, not recruitingSep 14, 202630
NCT06965413Obesity · United States, Poland, Spain and more2Active, not recruitingSep 3, 2026285
NCT05548556Muscular Dystrophy, Facioscapulohumeral · United States, Denmark, Italy and more2CompletedMay 2, 202551
NCT05115110Muscular Atrophy, Spinal · United States, Australia, Belgium and more3CompletedNov 2, 202697
NCT04708847Healthy Volunteers · Netherlands1CompletedJun 3, 202230

How it is read

Names in the registry

  • “RO7204239”, 4 entries
  • “GYM329”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.